Collaboration provides a solution for a more in-depth analysis of cancer biomarkers BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and the leader in data-driven medicine, is partnering with Agilent to offer a comprehensive solution for cancer analysis. Through the partnership, the SOPHiA DDM™ Platform will be integrated […]

New deep learning capabilities will provide data and insight to inform property prioritization, novel structure design and literature-based analyses PRINCETON, NJ — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, is adding deep learning capabilities to D360, a leading scientific informatics software platform. The addition of novel A.I. will enable discovery scientists to integrate multiple structured […]

BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and the leader in data-driven medicine, today announced the University of Arkansas for Medical Sciences (UAMS), based in Little Rock, AR, will use SOPHiA GENETICS’ platform to support their clinical oncology research. Beginning this year, UAMS will implement the SOPHiA DDM™ platform to gain […]

Senior executive brings deep financial planning and analysis experience to leadership team. DALLAS – Form Bio, the breakthrough computational life sciences platform, today announced the appointment of Linda Murray as Chief Financial Officer. “We are excited to announce this important addition to Form Bio’s leadership team as we enter an exciting time in our development and evolution; […]

First partnership in the new QIAseq Platform Partnership to increase compatibility of QIAGEN NGS kits with third-party digital data-sharing and analytics companies Bringing together QIAGEN’s QIAseq reagent technology with SOPHiA GENETICS DDM platform to expand compatibility with data-driven medicine Collaboration to initially support somatic variant detection using QIAseq panels for homologous recombination repair (HRR) and […]

The New Solution uses SOPHiA DDM™ and aims to Benefit Cancer Research, Clinical Studies and Patient Care BOSTON & LAUSANNE, Switzerland — -SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced that Synergy Oncology, part of Synergy Laboratories, a full-service diagnostic laboratory based in Mobile, Alabama, will use SOPHiA DDM™ […]

ICRISAT and Eagle Genomics sign Memorandum of Understanding Internationally renowned science-based organisation and pioneering TechBio platform expected to deliver innovative nature-based solutions through exciting public-private relationship Networking microbiome science to tackle the world’s Grand Challenges including effects of climate change  Hyderabad, India: A new cooperation framework was signed today between the International Crops Research Institute for […]

New release of the market-leading platform automates assay analysis and simplifies access to consolidated assay information across the enterprise Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Screener® 20. The most comprehensive digital platform for assay analysis in Biopharma R&D, Genedata Screener shortens […]

John Battles joins executive team to lead and expand product and technical opportunities Genomenon®, an AI-driven genomics company, announced today that John Battles has been appointed Vice President of Engineering. Battles will be responsible for leading the technical vision and implementation to deliver leading edge precision medicine solutions. Before joining Genomenon, Battles led many successful […]

The expanded partnership aims to leverage the global SOPHiA DDM™ platform and multimodal algorithmic capabilities to lead a new era of precision oncology by improving early patient identification and diagnosis, optimizing clinical development, and accelerating adoption of innovative medications along the care pathway BOSTON & LAUSANNE, Switzerland — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator […]